Pacer Advisors Inc. raised its holdings in CVS Health Corp (NYSE:CVS) by 7.8% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 35,097 shares of the pharmacy operator’s stock after acquiring an additional 2,543 shares during the quarter. Pacer Advisors Inc.’s holdings in CVS Health were worth $2,854,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also bought and sold shares of the company. FMR LLC increased its position in CVS Health by 22.0% during the second quarter. FMR LLC now owns 30,150,634 shares of the pharmacy operator’s stock worth $2,425,920,000 after acquiring an additional 5,446,930 shares during the period. Boston Partners increased its holdings in CVS Health by 69.1% in the 2nd quarter. Boston Partners now owns 6,459,237 shares of the pharmacy operator’s stock valued at $519,711,000 after buying an additional 2,638,888 shares during the period. Ameriprise Financial Inc. increased its holdings in CVS Health by 30.2% in the 3rd quarter. Ameriprise Financial Inc. now owns 7,977,370 shares of the pharmacy operator’s stock valued at $648,683,000 after buying an additional 1,849,593 shares during the period. Parametric Portfolio Associates LLC increased its holdings in CVS Health by 71.5% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 3,949,854 shares of the pharmacy operator’s stock valued at $317,805,000 after buying an additional 1,647,168 shares during the period. Finally, Prudential Financial Inc. increased its holdings in CVS Health by 61.8% in the 2nd quarter. Prudential Financial Inc. now owns 2,946,531 shares of the pharmacy operator’s stock valued at $237,078,000 after buying an additional 1,125,400 shares during the period. Hedge funds and other institutional investors own 80.81% of the company’s stock.
In other CVS Health news, EVP Lisa Bisaccia sold 29,445 shares of CVS Health stock in a transaction dated Thursday, December 21st. The stock was sold at an average price of $75.00, for a total value of $2,208,375.00. Following the transaction, the executive vice president now owns 15,556 shares in the company, valued at $1,166,700. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.61% of the company’s stock.
CVS has been the topic of several recent analyst reports. Jefferies Group set a $76.00 target price on shares of CVS Health and gave the company a “hold” rating in a research note on Monday, December 4th. Robert W. Baird reduced their price target on shares of CVS Health from $85.00 to $80.00 and set a “neutral” rating on the stock in a research report on Friday, February 9th. ValuEngine downgraded shares of CVS Health from a “buy” rating to a “hold” rating in a research report on Friday, February 2nd. Vetr downgraded shares of CVS Health from a “buy” rating to a “hold” rating and set a $77.11 target price on the stock. in a research report on Thursday, January 4th. Finally, Royal Bank of Canada set a $95.00 target price on shares of CVS Health and gave the company a “buy” rating in a research report on Monday, December 4th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $87.82.
CVS Health Corp (NYSE:CVS) opened at $69.79 on Thursday. The company has a current ratio of 1.02, a quick ratio of 0.52 and a debt-to-equity ratio of 0.59. The firm has a market capitalization of $70,700.00, a price-to-earnings ratio of 11.83, a price-to-earnings-growth ratio of 1.18 and a beta of 0.92. CVS Health Corp has a 12-month low of $66.45 and a 12-month high of $84.00.
CVS Health (NYSE:CVS) last issued its quarterly earnings results on Thursday, February 8th. The pharmacy operator reported $1.92 EPS for the quarter, topping the Zacks’ consensus estimate of $1.88 by $0.04. CVS Health had a return on equity of 17.21% and a net margin of 3.58%. The company had revenue of $48.39 billion for the quarter, compared to analysts’ expectations of $47.54 billion. During the same quarter last year, the business earned $1.71 earnings per share. CVS Health’s revenue was up 5.3% on a year-over-year basis. sell-side analysts forecast that CVS Health Corp will post 6.44 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Friday, February 2nd. Shareholders of record on Wednesday, January 24th were given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 2.87%. The ex-dividend date of this dividend was Tuesday, January 23rd. CVS Health’s dividend payout ratio is presently 33.90%.
COPYRIGHT VIOLATION NOTICE: “CVS Health Corp (CVS) Shares Bought by Pacer Advisors Inc.” was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this news story on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2018/02/15/pacer-advisors-inc-acquires-2543-shares-of-cvs-health-corp-cvs-2.html.
About CVS Health
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.